411 related articles for article (PubMed ID: 23239392)
1. Looking at the (w)hole: magnet resonance imaging in polycystic kidney disease.
Liebau MC; Serra AL
Pediatr Nephrol; 2013 Sep; 28(9):1771-83. PubMed ID: 23239392
[TBL] [Abstract][Full Text] [Related]
2. Rationale for early treatment of polycystic kidney disease.
Grantham JJ
Pediatr Nephrol; 2015 Jul; 30(7):1053-62. PubMed ID: 25022529
[TBL] [Abstract][Full Text] [Related]
3. Polycystic kidney disease: etiology, pathogenesis, and treatment.
Martinez JR; Grantham JJ
Dis Mon; 1995 Nov; 41(11):693-765. PubMed ID: 7587886
[TBL] [Abstract][Full Text] [Related]
4. The spectrum of polycystic kidney disease in children.
Dell KM
Adv Chronic Kidney Dis; 2011 Sep; 18(5):339-47. PubMed ID: 21896375
[TBL] [Abstract][Full Text] [Related]
5. [Polycystic kidney diseases: molecular genetics and counselling].
Lespinasse J; Fourcade J; Schir F
Nephrol Ther; 2006 Jul; 2(3):120-6. PubMed ID: 16890136
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiology of childhood polycystic kidney diseases: new insights into disease-specific therapy.
Sweeney WE; Avner ED
Pediatr Res; 2014 Jan; 75(1-2):148-57. PubMed ID: 24336431
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in the molecular diagnosis of polycystic kidney disease.
Bergmann C
Expert Rev Mol Diagn; 2017 Dec; 17(12):1037-1054. PubMed ID: 28952822
[TBL] [Abstract][Full Text] [Related]
8. Accuracy and processing time of kidney volume measurement methods in rodents polycystic kidney disease models: superiority of semiautomated kidney segmentation.
Doss MC; Mullen S; Roye R; Zhou J; Chumley P; Mrug E; Wallace DP; Qian F; Harris PC; Yoder BK; Kim H; Mrug M
Am J Physiol Renal Physiol; 2023 Apr; 324(4):F423-F430. PubMed ID: 36794756
[TBL] [Abstract][Full Text] [Related]
9. [Clinical practice guidelines for polycystic kidney diseases].
Writing Group For Practice Guidelines For Diagnosis And Treatment Of Genetic Diseases Medical Genetics Branch Of Chinese Medical Association ; Xu D; Mei C
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Mar; 37(3):277-283. PubMed ID: 32128744
[TBL] [Abstract][Full Text] [Related]
10. Polycystic kidney disease.
Bergmann C; Guay-Woodford LM; Harris PC; Horie S; Peters DJM; Torres VE
Nat Rev Dis Primers; 2018 Dec; 4(1):50. PubMed ID: 30523303
[TBL] [Abstract][Full Text] [Related]
11. The Clinical and Mutational Spectrum of 69 Turkish Children with Autosomal Recessive or Autosomal Dominant Polycystic Kidney Disease: A Multicenter Retrospective Cohort Study.
Tutal O; Gulhan B; Atayar E; Yuksel S; Ozcakar ZB; Soylemezoglu O; Saygili S; Caliskan S; Inozu M; Baskin E; Duzova A; Hayran M; Topaloglu R; Ozaltin F
Nephron; 2024; 148(5):319-332. PubMed ID: 36657418
[TBL] [Abstract][Full Text] [Related]
12. Renal cyst evolution in childhood: a contemporary observational study.
Rediger C; Guerra LA; Keays MA; Wayne C; Reddy D; Ksara S; Leonard MP
J Pediatr Urol; 2019 Apr; 15(2):188.e1-188.e6. PubMed ID: 30808538
[TBL] [Abstract][Full Text] [Related]
13. The Jeremiah Metzger Lecture. Polycystic kidney disease: old disease in a new context.
Grantham JJ
Trans Am Clin Climatol Assoc; 2002; 113():211-24; discussion 224-6. PubMed ID: 12053711
[TBL] [Abstract][Full Text] [Related]
14. Assessing Risk of Rapid Progression in Autosomal Dominant Polycystic Kidney Disease and Special Considerations for Disease-Modifying Therapy.
Chebib FT; Torres VE
Am J Kidney Dis; 2021 Aug; 78(2):282-292. PubMed ID: 33705818
[TBL] [Abstract][Full Text] [Related]
15. Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease: A Biomarker of Disease Progression and Therapeutic Efficacy.
Alam A; Dahl NK; Lipschutz JH; Rossetti S; Smith P; Sapir D; Weinstein J; McFarlane P; Bichet DG
Am J Kidney Dis; 2015 Oct; 66(4):564-76. PubMed ID: 25960302
[TBL] [Abstract][Full Text] [Related]
16. A rapid high-performance semi-automated tool to measure total kidney volume from MRI in autosomal dominant polycystic kidney disease.
Simms RJ; Doshi T; Metherall P; Ryan D; Wright P; Gruel N; van Gastel MDA; Gansevoort RT; Tindale W; Ong ACM
Eur Radiol; 2019 Aug; 29(8):4188-4197. PubMed ID: 30666443
[TBL] [Abstract][Full Text] [Related]
17. Predictors of progression in autosomal dominant and autosomal recessive polycystic kidney disease.
Benz EG; Hartung EA
Pediatr Nephrol; 2021 Sep; 36(9):2639-2658. PubMed ID: 33474686
[TBL] [Abstract][Full Text] [Related]
18. The importance of total kidney volume in evaluating progression of polycystic kidney disease.
Grantham JJ; Torres VE
Nat Rev Nephrol; 2016 Nov; 12(11):667-677. PubMed ID: 27694979
[TBL] [Abstract][Full Text] [Related]
19. Hypomagnesaemia is absent in children with autosomal dominant polycystic kidney disease.
Seeman T; Fořtová M; Sopko B; Průša R; Pohl M; John U
Ann Clin Biochem; 2019 Jan; 56(1):90-94. PubMed ID: 29874928
[TBL] [Abstract][Full Text] [Related]
20. Plasma metabolites and lipids associate with kidney function and kidney volume in hypertensive ADPKD patients early in the disease course.
Kim K; Trott JF; Gao G; Chapman A; Weiss RH
BMC Nephrol; 2019 Feb; 20(1):66. PubMed ID: 30803434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
